Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Hold
0
7053
2025
Q3
Hold
0
7027
2025
Q2
Hold
0
7076
2025
Q1
Hold
0
6986
2024
Q4
Hold
0
7009
2024
Q3
Sell
-1,684
Closed -$5.55K 6854
2024
Q2
$5.73K Sell
1,684
-1,667
-50% -$5.45K ﹤0.01% 5858
2024
Q1
$10.2K Buy
3,351
+3,041
+981% +$10.7K ﹤0.01% 5758
2023
Q4
$1.31K Hold
310
﹤0.01% 6168
2023
Q3
$2.12K Sell
310
-90
-23% -$795 ﹤0.01% 6089
2023
Q2
$4.17K Sell
400
-400
-50% -$3.58K ﹤0.01% 6102
2023
Q1
$5.58K Sell
800
-101
-11% -$880 ﹤0.01% 6022
2022
Q4
$5.43K Buy
901
+100
+12% +$739 ﹤0.01% 5746
2022
Q3
$7K Sell
801
-448
-36% -$5.22K ﹤0.01% 5803
2022
Q2
$17K Buy
1,249
+831
+199% +$13.7K ﹤0.01% 5523
2022
Q1
$8K Sell
418
-259
-38% -$5.17K ﹤0.01% 6338
2021
Q4
$24K Buy
677
+275
+68% +$11.1K ﹤0.01% 6268
2021
Q3
$22K Sell
402
-300
-43% -$18.1K ﹤0.01% 5942
2021
Q2
$51K Sell
702
-746
-52% -$74.6K ﹤0.01% 5547
2021
Q1
$132K Buy
1,448
+1,158
+399% +$112K ﹤0.01% 5352
2020
Q4
$24K Buy
290
+40
+16% +$3.06K ﹤0.01% 5808
2020
Q3
$12K Buy
+250
New +$13.9K ﹤0.01% 5849

Other funds holding CVAC

Wells Fargo's CVAC Position: Q4 2025 in Review

Wells Fargo held its CureVac (CVAC) position steady in Q4 2025 at 0 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #7053.

Wells Fargo first reported a position in CVAC in Q3 2020 and has held it in 16 quarters since. The position peaked at $132K in Q1 2021. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

  • Wells Fargo held 0 shares of CureVac worth $1 as of Q4 2025.
  • Wells Fargo left its CureVac share count unchanged in Q4 2025.
  • CureVac made up ﹤0.01% of Wells Fargo's portfolio in Q4 2025, its #7053 holding.
  • Wells Fargo first reported a position in CureVac in Q3 2020 and has held it in 16 quarters since.
  • Wells Fargo's CureVac position peaked at $132K in Q1 2021.
  • 57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Wells Fargo's 13F filing for Q4 2025, filed 13 Feb 2026.